Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methenamine hippurate versus prophylactic antibiotics for recurrent urinary tract infection in women
2015-003487-36Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Dec 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methenamine hippurate, trimethoprim, nitrofurantoin and cefalexin in urinary tract infection (UTI) (2 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoints: Primary clinical outcome and Rate of urinary tract infection. Started Dec 2015; status: completed.
02
Drugs
methenamine hippuratetrimethoprimnitrofurantoincefalexin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2015-003487-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003487-36.